 | ||||||||||||||||||||||||||||||||||||
 |
PASSION FOR IDEAS |
|||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
|
|
GeneSystemsGeneSystems is a French biotechnology company positioned on the molecular diagnostics markets through its offer of innovative products. The GeneExtract and GeneDisc Cycler platforms are part of the first integrated system for the rapid diagnosis of pathogens (Listeria 24 hours, Salmonella 18 hours, Legionella 3 hours, etc.) that is easy to use and competitive.
September 8, 2008 Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems May 14, 2008 Bureaucracy Hampers an E. coli Weapon |
|
|
|
|||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
| partner of the European Tech Tour |  |
"The partners have been very supportive of our approach and stepped in to add value when needed. I would strongly recommend them as investors." Didier Cowling, Founder and CEO, Kuros Biosurgery AG |
||||||||||||||||||||||||||||||||||
technology
semiconductor & hardware
Damien Tappy